As senior figures from the UK biopharma industry gathered in a gloomy London for the Annual Conference of The Association of the British Pharmaceutical Industry 28 April 2023
At present, cancer vaccines are available mainly as part of clinical trials but, with ambitious biotech companies starting to grab the attention of big pharma a 20 April 2023
An analysis of the recent investment activity in antibody–drug conjugates (ADCs) prior to Pfizer's newly-announced $43 billion takeover of Seagen. 13 March 2023
There is no shortage of criticism currently being directed at the UK government from the public sector, especially where healthcare is concerned. 18 January 2023
Pharma companies continue to evaluate novel ways to increase their return on investment and generate shareholder value, basic earnings per share (EPS), plus sto 19 September 2022
Last month, Belgo-Dutch autoimmune diseases specialist argenx announced the European Commission (EC) approval of Vyvgart (efgartigimod alfa-fcab) as an add-on t 19 September 2022
The annual meeting of the European Society of Medical Oncology (ESMO) kicks off in Paris on 9 September.and early indications are the event could be full of pra 29 August 2022
As President Joe Biden signs the Inflation Reduction Act into law.drugmakers in the USA are poring over the likely impact on drug prices.and how best to respond 17 August 2022
The pandemic revolutionized data collection and patient engagement in clinical trials.Although the life sciences industry has been historically cautious to adop 12 July 2022
One UK-based company is looking to transform the way metabolic disorders are treated, leveraging many of the same AI-based techniques used to great effect elsew 4 July 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.